Sio Capital Management, LLC Sage Therapeutics, Inc. Put Options Transaction History

Sio Capital Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $1.1 Million - $3.24 Million	-41,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $2.52 Million - $6.48 Million	41,900 New	41,900 $3.03 Million
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $27.3 Million - $34.5 Million	-179,200 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $680,064 - $1.87 Million	-11,200 Reduced 5.88%	179,200 $29.5 Million
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $11.7 Million - $16.9 Million	190,400	190,400 $11.9 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.